Noseworthy John H 4

What Happened
John H. Noseworthy, a director of UnitedHealth Group (UNH), was credited with 41 shares on 2026-06-23 as an award/acquisition (code A) at $0.00 per share (total reported value $0). This was not an open-market purchase or sale but dividend equivalents paid on vested deferred stock units that were immediately vested.

Key Details

• Transaction date: 2026-06-23; Form 4 filed: 2026-06-25 (timely filing).
• Transaction type/code: Award/other acquisition (A). Price: $0.00; Shares acquired: 41; Reported value: $0.
• Shares owned after transaction: Not specified in the provided filing.
• Footnote: F1 — these 41 shares represent dividend equivalents paid on vested deferred stock units; the dividend equivalents are immediately vested and follow the same terms as the underlying deferred units.
• Filing timeliness: Filing appears timely (filed within required reporting window).

Context
Dividend-equivalent awards are a form of compensation that converts dividends on deferred stock units into shares; they do not reflect an out-of-pocket purchase and are generally routine compensation rather than a directional insider market signal.